679
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

NMU DNA methylation in blood is associated with metabolic and inflammatory indices: results from the Moli-sani study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1347-1360 | Received 15 Jul 2020, Accepted 08 Dec 2020, Published online: 04 Jan 2021

References

  • Kassi E, Pervanidou P, Kaltsas G, et al. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48.
  • Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867.
  • Martinez VG, O’Driscoll L. Neuromedin U: a multifunctional neuropeptide with pleiotropic roles. Clin Chem. 2015;61:471–482.
  • Gajjar S, Patel BM. Neuromedin: an insight into its types, receptors and therapeutic opportunities. Pharmacol Rep. 2017;69:438–447.
  • Moriyama M, Fukuyama S, Inoue H, et al. The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. Am J Physiol Lung Cell Mol Physiol. 2006;290:L971–977.
  • Hedrick JA, Morse K, Shan L, et al. Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol Pharmacol. 2000;58:870–875.
  • Klose CSN, Mahlakoiv T, Moeller JB, et al. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature. 2017;549:282–286.
  • Grippi C, Izzi B, Gianfagna F, et al. Neuromedin U potentiates ADP- and epinephrine-induced human platelet activation. Thromb Res. 2017;159:100–108.
  • Hainerova I, Torekov SS, Ek J, et al. Association between neuromedin U gene variants and overweight and obesity. J Clin Endocrinol Metab. 2006;91:5057–5063.
  • Gianfagna F, Grippi C, Ahrens W, et al. The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort. PLoS One. 2017;12:e0172698.
  • Grippi C, Ahrens W, Buchecker K, et al. Association between variants of neuromedin U gene and taste thresholds and food preferences in European children: results from the IDEFICS study. Appetite. 2019;142:104376.
  • Gianfagna F, Cugino D, Ahrens W, et al. Understanding the links among neuromedin U gene, beta2-adrenoceptor gene and bone health: an observational study in European children. PLoS One. 2013;8(8):e70632. .
  • Carson C, Lawson HA. Epigenetics of metabolic syndrome. Physiol Genomics. 2018;50:947–955.
  • Tobi EW, Lumey LH, Talens RP, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009;18:4046–4053.
  • Arpon A, Milagro FI, Ramos-Lopez O, et al. Methylome-wide association study in peripheral white blood cells focusing on central obesity and inflammation. Genes (Basel). 2019;10(6):444. .
  • Di Castelnuovo A, de Curtis A, Costanzo S, et al. Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. Haematologica. 2013;98:1476–1480.
  • Di Castelnuovo A, Costanzo S, Persichillo M, et al. Distribution of short and lifetime risks for cardiovascular disease in Italians. Eur J Prev Cardiol. 2012;19:723–730.
  • Pisani P, Faggiano F, Krogh V, et al. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol. 1997;26(Suppl 1):S152–160.
  • Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599–2608.
  • Bener A, Zirie M, Musallam M, et al. Prevalence of metabolic syndrome according to adult treatment panel III and international diabetes federation criteria: a population-based study. Metab Syndr Relat Disord. 2009;7:221–229.
  • National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults–The evidence report. Obes Res. 1998;6(Suppl 2):51S–209S.
  • Zeller T, Hughes M, Tuovinen T, et al. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol. 2014;29:777–790.
  • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
  • Pounis G, Bonaccio M, Di Castelnuovo A, et al. Polyphenol intake is associated with low-grade inflammation, using a novel data analysis from the Moli-sani study. Thromb Haemost. 2016;2115:344–352.
  • Gialluisi A, Bonaccio M, Di Castelnuovo A, et al. Lifestyle and biological factors influence the relationship between mental health and low-grade inflammation. Brain Behav Immun. 2020;85:4–13.
  • Bonaccio M, Di Castelnuovo A, Pounis G, et al. A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study. Haematologica. 2016;101:1434–1441.
  • Malferrari G, Monferini E, DeBlasio P, et al. High-quality genomic DNA from human whole blood and mononuclear cells. Biotechniques. 2002;33:1228–1230.
  • Izzi B, Binder AM, Michels KB. Pyrosequencing evaluation of widely available bisulfite conversion methods: considerations for application. Med Epigenet. 2014;2:28–36.
  • Noro F, Gianfagna F, Gialluisi A, et al. ZBTB12 DNA methylation is associated with coagulation- and inflammation-related blood cell parameters: findings from the Moli-family cohort. Clin Epigenetics. 2019;11(1):74. .
  • Izzi B, Gianfagna F, Yang WY, et al. Variation of PEAR1 DNA methylation influences platelet and leukocyte function. Clin Epigenetics. 2019;11:151.
  • Kim JOMC. Factor analysis: statistical method and practical issues. Thousand Oaks, CA: Sage Publications; 1978.
  • Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36:717–731.
  • Messeguer X, Escudero R, Farre D, et al. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18:333–334.
  • Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4:1287–1295.
  • Ingallinella P, Peier AM, Pocai A, et al. PEGylation of neuromedin U yields a promising candidate for the treatment of obesity and diabetes. Bioorg Med Chem. 2012;20:4751–4759.
  • Ma ML, Li M, Gou JJ, et al. Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor. Bioorg Med Chem. 2014;22(21):6117–6123.
  • De Prins A, Van Eeckhaut A, Smolders I, et al. Neuromedin U and structural analogs: an overview of their structure, function and selectivity. Curr Med Chem. 2020;27(39):6744-6768.
  • Shetzline SE, Rallapalli R, Dowd KJ, et al. Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. Blood. 2004;104:1833–1840.
  • Gambone JE, Dusaban SS, Loperena R, et al. The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis. Blood. 2011;117:5733–5743.
  • Moriyama M, Sato T, Inoue H, et al. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells. J Exp Med. 2005;202:217–224.
  • Moriyama M, Matsukawa A, Kudoh S, et al. The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock. Biochem Biophys Res Commun. 2006;341:1149–1154.
  • Nagashima H, Mahlakoiv T, Shih HY, et al. Neuropeptide CGRP limits Group 2 innate lymphoid cell responses and constrains type 2 inflammation. Immunity. 2019;51:682–695 e686.
  • Stols-Goncalves D, Tristao LS, Henneman P, et al. Epigenetic markers and microbiota/metabolite-induced epigenetic modifications in the pathogenesis of obesity, metabolic syndrome, Type 2 diabetes, and non-alcoholic fatty liver disease. Curr Diab Rep. 2019;19:31.
  • Ligthart S, Marzi C, Aslibekyan S, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17:255.
  • Marzi C, Holdt LM, Fiorito G, et al. Epigenetic signatures at AQP3 and SOCS3 engage in low-grade inflammation across different tissues. PLoS One. 2016;11:e0166015.
  • Izzi B, Noro F, Cludts K, et al. Cell-specific PEAR1 methylation studies reveal a locus that coordinates expression of multiple genes. Int J Mol Sci. 2018;19(4):1069.
  • Morrison FG, Logue MW, Guetta R, et al. Investigation of bidirectional longitudinal associations between advanced epigenetic age and peripheral biomarkers of inflammation and metabolic syndrome. Aging (Albany NY). 2019;11:3487–3504.
  • Wahl S, Drong A, Lehne B, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81–86.
  • Dick KJ, Nelson CP, Tsaprouni L, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014;383:1990–1998.
  • Feinberg AP, Irizarry RA, Fradin D, et al. Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med. 2010;2:49ra67.
  • Xu X, Su S, Barnes VA, et al. A genome-wide methylation study on obesity: differential variability and differential methylation. Epigenetics. 2013;8:522–533.
  • Demerath EW, Guan W, Grove ML, et al. Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. Hum Mol Genet. 2015;24:4464–4479.
  • Singhal A, Subramanian M. Colony stimulating factors (CSFs): complex roles in atherosclerosis. Cytokine. 2019;122:154190.
  • Quach A, Levine ME, Tanaka T, et al. Epigenetic clock analysis of diet, exercise, education, and lifestyle factors. Aging (Albany NY). 2017;9:419–446.
  • Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23–38.
  • Jimenez MA, Akerblad P, Sigvardsson M, et al. Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Mol Cell Biol. 2007;27:743–757. .
  • Friedman AD. Transcriptional regulation of granulocyte and monocyte development. Oncogene. 2002;21:3377–3390.
  • Friedman AD. Transcriptional regulation of myelopoiesis. Int J Hematol. 2002;75:466–472.
  • Jalinot P, Devaux B, Kedinger C. The abundance and in vitro DNA binding of three cellular proteins interacting with the adenovirus EIIa early promoter are not modified by the EIa gene products. Mol Cell Biol. 1987;7:3806–3817.
  • Ginsberg D, Vairo G, Chittenden T, et al. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 1994;8:2665–2679.
  • Laurendi G, Donfrancesco C, Palmieri L, et al. Association of lifestyle and cardiovascular risk factors with lung function in a sample of the adult Italian population: a cross-sectional survey. Respiration. 2015;89:33–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.